One factor unquestionably distinguishes the two formulations of buprenorphine: cost! Thus, there are at least seven major firms in the US that provide a 30-day supply of generic buprenorphine without naloxone for \$80 or less,[@b6-sart-7-2013-107] compared to the "wholesale average price" of \$252 for the same quantity of Suboxone sublingual tablets, and \$211 for Suboxone film, which remains patent-protected.[@b7-sart-7-2013-107] Clearly, the fiscal benefits to the manufacturer of the combined product come at the expense of patients and their insurers---if the patients have insurance. Inevitably, that expense will prove impossible for many to bear, and the result will often be loss of access to a potentially life-saving medication.
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